The inhibition of BCL6 or mTOR can reverse the resistance of tumor cells [126].In addition, the activation of the MAPK signaling pathway [127], c – MYC [128], etc., also contributes to the induction of tumor resistance. Here, BCL6 is linked to neoplasm.